Maharashtra signs strategic MoU with UK-based Causis E-Mobility as it aims to become EV hub
India

Maharashtra signs strategic MoU with UK-based Causis E-Mobility as it aims to become EV hub

The partnership aims to set up a EV plant in Maharashtra’s Talegaon. Under the MoU, Rs 2,823 crore investment will be made and 1,250 jobs will be created.

   
MIDC

MIDC signs MoU with Causis E-Mobility to set up EV plant in Maharashtra | Twitter | @midc_india

New Delhi: With an aim to ease manufacturing of electrical vehicles and move closer to a zero-emission target, Causis E-Mobility and Maharashtra Industrial Development Corporation (MIDC) signed a Memorandum of Understanding (MoU) in the presence of Subhash Desai, Minister of Industries, Aaditya Thackeray, Minister of Environment, Baldev Singh, ACS Industries and IAS, and P. Anbalagan, CEO, MIDC.

“The transition to electric vehicles from conventional fleets requires a planned strategy that not only overlooks the merging of the energy and transportation sector but also enhances the relationships between consumers and vehicles,” an MIDC press release noted.

Under the MoU, 59th such of the Maharashtra government, an Rs 2,823 crore investment will be made and 1,250 jobs will be created. A total of Rs 1.67,762 lakh crore has been invested through MoUs, as the government aims to make the state — which is already a leading hub in automobile manufacturing — a hub for electric vehicles and battery manufacturing. This partnership aims to set up a plant in MIDC Industrial Phase 5 in Maharashtra’s Talegaon.

Causis is now aiming to make another EV battery supply Gigafactory in Maharashtra, the first such is being planned in the United Kingdom. With this, Mumbai, Pune, Nagpur, Aurangabad and Nashik will have 25 per cent EV share in public transport.

Causis E-Mobility, headquartered in London, “is part of Causis Group which manufactures and supplies high-volume zero-emission electric vehicles including the associated infrastructure of chargers and renewable energy.”


Also read: MIDC signs ‘strategic investment initiative’ with Reliance Life Sciences